Item 1A. Risk Factors

As of June 30, 2024, there have been no material changes to the risk factors set forth in our annual report on Form 10-K for the year ended December 31, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The Company had no sales of unregistered securities during the six months ended June 30, 2024. The following table identifies all repurchases during the three months ended June 30, 2024, of any of the Company’s securities registered under Section 12 of the Securities Exchange Act of 1934, as amended, by or on behalf of the Company or any affiliated purchaser (in thousands, except per share data):


				Total Number of	Maximum Dollar Value
	Total	Average		Shares Purchased as	of Shares that May Yet
	Number of	Price Paid		Part of Publicly	Be Purchased Under the
Period	Shares Purchased	per Share		Announced Programs	Programs (1)
April 1, 2024, to April 30, 2024	100	$	1,090.01	100	$	2,193,509
May 1, 2024, to May 31, 2024	396		1,000.88	396		1,796,935
June 1, 2024, to June 30, 2024	289		1,000.68	289	$	1,508,420
Total as of June 30, 2024	785	$	1,012.14	785

(1)	The authorization under the share repurchase program that currently has capacity is scheduled to expire on November 16, 2026. No other share repurchase programs existed during the six months ended June 30, 2024. See Note 9 “Share Repurchase Program” to the Condensed Consolidated Financial Statements for further information on our share repurchases.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information